nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Nausea—Carmustine—hematologic cancer	0.000158	0.000193	CcSEcCtD
Glycopyrrolate—Epistaxis—Doxorubicin—hematologic cancer	0.000158	0.000193	CcSEcCtD
Glycopyrrolate—Vomiting—Irinotecan—hematologic cancer	0.000158	0.000192	CcSEcCtD
Glycopyrrolate—Vomiting—Mitoxantrone—hematologic cancer	0.000158	0.000192	CcSEcCtD
Glycopyrrolate—Sinusitis—Doxorubicin—hematologic cancer	0.000157	0.000192	CcSEcCtD
Glycopyrrolate—Nausea—Alitretinoin—hematologic cancer	0.000157	0.000191	CcSEcCtD
Glycopyrrolate—Convulsion—Prednisone—hematologic cancer	0.000157	0.000191	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Methotrexate—hematologic cancer	0.000157	0.000191	CcSEcCtD
Glycopyrrolate—Hypertension—Prednisone—hematologic cancer	0.000156	0.000191	CcSEcCtD
Glycopyrrolate—Rash—Mitoxantrone—hematologic cancer	0.000156	0.000191	CcSEcCtD
Glycopyrrolate—Rash—Irinotecan—hematologic cancer	0.000156	0.000191	CcSEcCtD
Glycopyrrolate—Dermatitis—Irinotecan—hematologic cancer	0.000156	0.000191	CcSEcCtD
Glycopyrrolate—Dermatitis—Mitoxantrone—hematologic cancer	0.000156	0.000191	CcSEcCtD
Glycopyrrolate—Headache—Mitoxantrone—hematologic cancer	0.000155	0.000189	CcSEcCtD
Glycopyrrolate—Headache—Irinotecan—hematologic cancer	0.000155	0.000189	CcSEcCtD
Glycopyrrolate—Nausea—Ifosfamide—hematologic cancer	0.000155	0.000189	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Triamcinolone—hematologic cancer	0.000154	0.000188	CcSEcCtD
Glycopyrrolate—Vomiting—Gemcitabine—hematologic cancer	0.000154	0.000187	CcSEcCtD
Glycopyrrolate—Insomnia—Dexamethasone—hematologic cancer	0.000154	0.000187	CcSEcCtD
Glycopyrrolate—Insomnia—Betamethasone—hematologic cancer	0.000154	0.000187	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000153	0.000187	CcSEcCtD
Glycopyrrolate—Mental disorder—Methotrexate—hematologic cancer	0.000152	0.000186	CcSEcCtD
Glycopyrrolate—Rash—Gemcitabine—hematologic cancer	0.000152	0.000186	CcSEcCtD
Glycopyrrolate—Dermatitis—Gemcitabine—hematologic cancer	0.000152	0.000186	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Etoposide—hematologic cancer	0.000152	0.000185	CcSEcCtD
Glycopyrrolate—Malnutrition—Methotrexate—hematologic cancer	0.000151	0.000185	CcSEcCtD
Glycopyrrolate—Erythema—Methotrexate—hematologic cancer	0.000151	0.000185	CcSEcCtD
Glycopyrrolate—Headache—Gemcitabine—hematologic cancer	0.000151	0.000185	CcSEcCtD
Glycopyrrolate—Nausea—Vincristine—hematologic cancer	0.000151	0.000184	CcSEcCtD
Glycopyrrolate—Flushing—Epirubicin—hematologic cancer	0.000151	0.000184	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Epirubicin—hematologic cancer	0.000151	0.000184	CcSEcCtD
Glycopyrrolate—Rhinitis—Doxorubicin—hematologic cancer	0.000151	0.000184	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Prednisolone—hematologic cancer	0.00015	0.000183	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Doxorubicin—hematologic cancer	0.00015	0.000183	CcSEcCtD
Glycopyrrolate—Dyspepsia—Dexamethasone—hematologic cancer	0.000149	0.000182	CcSEcCtD
Glycopyrrolate—Dyspepsia—Betamethasone—hematologic cancer	0.000149	0.000182	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Doxorubicin—hematologic cancer	0.000149	0.000181	CcSEcCtD
Glycopyrrolate—Urticaria—Triamcinolone—hematologic cancer	0.000149	0.000181	CcSEcCtD
Glycopyrrolate—Dysgeusia—Methotrexate—hematologic cancer	0.000148	0.000181	CcSEcCtD
Glycopyrrolate—Asthenia—Etoposide—hematologic cancer	0.000148	0.00018	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Doxorubicin—hematologic cancer	0.000148	0.00018	CcSEcCtD
Glycopyrrolate—Body temperature increased—Triamcinolone—hematologic cancer	0.000148	0.00018	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Prednisone—hematologic cancer	0.000148	0.00018	CcSEcCtD
Glycopyrrolate—Oedema—Prednisone—hematologic cancer	0.000148	0.00018	CcSEcCtD
Glycopyrrolate—Urethral disorder—Doxorubicin—hematologic cancer	0.000148	0.00018	CcSEcCtD
Glycopyrrolate—Nausea—Irinotecan—hematologic cancer	0.000147	0.00018	CcSEcCtD
Glycopyrrolate—Nausea—Mitoxantrone—hematologic cancer	0.000147	0.00018	CcSEcCtD
Glycopyrrolate—Infection—Prednisone—hematologic cancer	0.000147	0.000179	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Epirubicin—hematologic cancer	0.000147	0.000179	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000147	0.000179	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000147	0.000179	CcSEcCtD
Glycopyrrolate—Fatigue—Dexamethasone—hematologic cancer	0.000146	0.000179	CcSEcCtD
Glycopyrrolate—Fatigue—Betamethasone—hematologic cancer	0.000146	0.000179	CcSEcCtD
Glycopyrrolate—Pruritus—Etoposide—hematologic cancer	0.000146	0.000178	CcSEcCtD
Glycopyrrolate—Pain—Dexamethasone—hematologic cancer	0.000145	0.000177	CcSEcCtD
Glycopyrrolate—Pain—Betamethasone—hematologic cancer	0.000145	0.000177	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Prednisone—hematologic cancer	0.000145	0.000177	CcSEcCtD
Glycopyrrolate—Tachycardia—Prednisone—hematologic cancer	0.000144	0.000176	CcSEcCtD
Glycopyrrolate—Skin disorder—Prednisone—hematologic cancer	0.000144	0.000175	CcSEcCtD
Glycopyrrolate—Nausea—Gemcitabine—hematologic cancer	0.000144	0.000175	CcSEcCtD
Glycopyrrolate—Vomiting—Cisplatin—hematologic cancer	0.000143	0.000175	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Prednisone—hematologic cancer	0.000143	0.000174	CcSEcCtD
Glycopyrrolate—Vision blurred—Methotrexate—hematologic cancer	0.000143	0.000174	CcSEcCtD
Glycopyrrolate—Mental disorder—Epirubicin—hematologic cancer	0.000143	0.000174	CcSEcCtD
Glycopyrrolate—Rash—Cisplatin—hematologic cancer	0.000142	0.000173	CcSEcCtD
Glycopyrrolate—Dermatitis—Cisplatin—hematologic cancer	0.000142	0.000173	CcSEcCtD
Glycopyrrolate—Malnutrition—Epirubicin—hematologic cancer	0.000142	0.000173	CcSEcCtD
Glycopyrrolate—Erythema—Epirubicin—hematologic cancer	0.000142	0.000173	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Betamethasone—hematologic cancer	0.00014	0.000171	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Dexamethasone—hematologic cancer	0.00014	0.000171	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Doxorubicin—hematologic cancer	0.00014	0.00017	CcSEcCtD
Glycopyrrolate—Flushing—Doxorubicin—hematologic cancer	0.00014	0.00017	CcSEcCtD
Glycopyrrolate—Flatulence—Epirubicin—hematologic cancer	0.00014	0.00017	CcSEcCtD
Glycopyrrolate—Tension—Epirubicin—hematologic cancer	0.000139	0.00017	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000139	0.000169	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000139	0.000169	CcSEcCtD
Glycopyrrolate—Dysgeusia—Epirubicin—hematologic cancer	0.000139	0.000169	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Triamcinolone—hematologic cancer	0.000138	0.000168	CcSEcCtD
Glycopyrrolate—Nervousness—Epirubicin—hematologic cancer	0.000138	0.000168	CcSEcCtD
Glycopyrrolate—Dizziness—Etoposide—hematologic cancer	0.000136	0.000166	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Doxorubicin—hematologic cancer	0.000136	0.000166	CcSEcCtD
Glycopyrrolate—Urticaria—Dexamethasone—hematologic cancer	0.000135	0.000164	CcSEcCtD
Glycopyrrolate—Urticaria—Betamethasone—hematologic cancer	0.000135	0.000164	CcSEcCtD
Glycopyrrolate—Dizziness—Prednisolone—hematologic cancer	0.000135	0.000164	CcSEcCtD
Glycopyrrolate—Asthenia—Triamcinolone—hematologic cancer	0.000134	0.000164	CcSEcCtD
Glycopyrrolate—Abdominal pain—Betamethasone—hematologic cancer	0.000134	0.000164	CcSEcCtD
Glycopyrrolate—Abdominal pain—Dexamethasone—hematologic cancer	0.000134	0.000164	CcSEcCtD
Glycopyrrolate—Body temperature increased—Betamethasone—hematologic cancer	0.000134	0.000164	CcSEcCtD
Glycopyrrolate—Body temperature increased—Dexamethasone—hematologic cancer	0.000134	0.000164	CcSEcCtD
Glycopyrrolate—Nausea—Cisplatin—hematologic cancer	0.000134	0.000163	CcSEcCtD
Glycopyrrolate—Insomnia—Prednisone—hematologic cancer	0.000134	0.000163	CcSEcCtD
Glycopyrrolate—Vision blurred—Epirubicin—hematologic cancer	0.000134	0.000163	CcSEcCtD
Glycopyrrolate—Pruritus—Triamcinolone—hematologic cancer	0.000132	0.000161	CcSEcCtD
Glycopyrrolate—Mental disorder—Doxorubicin—hematologic cancer	0.000132	0.000161	CcSEcCtD
Glycopyrrolate—Convulsion—Methotrexate—hematologic cancer	0.000131	0.00016	CcSEcCtD
Glycopyrrolate—Vomiting—Etoposide—hematologic cancer	0.000131	0.00016	CcSEcCtD
Glycopyrrolate—Erythema—Doxorubicin—hematologic cancer	0.000131	0.00016	CcSEcCtD
Glycopyrrolate—Malnutrition—Doxorubicin—hematologic cancer	0.000131	0.00016	CcSEcCtD
Glycopyrrolate—Agitation—Epirubicin—hematologic cancer	0.00013	0.000159	CcSEcCtD
Glycopyrrolate—Dyspepsia—Prednisone—hematologic cancer	0.00013	0.000159	CcSEcCtD
Glycopyrrolate—Rash—Etoposide—hematologic cancer	0.00013	0.000159	CcSEcCtD
Glycopyrrolate—Dermatitis—Etoposide—hematologic cancer	0.00013	0.000158	CcSEcCtD
Glycopyrrolate—Headache—Etoposide—hematologic cancer	0.000129	0.000158	CcSEcCtD
Glycopyrrolate—Flatulence—Doxorubicin—hematologic cancer	0.000129	0.000158	CcSEcCtD
Glycopyrrolate—Tension—Doxorubicin—hematologic cancer	0.000129	0.000157	CcSEcCtD
Glycopyrrolate—Dysgeusia—Doxorubicin—hematologic cancer	0.000128	0.000157	CcSEcCtD
Glycopyrrolate—Rash—Prednisolone—hematologic cancer	0.000128	0.000156	CcSEcCtD
Glycopyrrolate—Dermatitis—Prednisolone—hematologic cancer	0.000128	0.000156	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000128	0.000156	CcSEcCtD
Glycopyrrolate—Fatigue—Prednisone—hematologic cancer	0.000127	0.000155	CcSEcCtD
Glycopyrrolate—Headache—Prednisolone—hematologic cancer	0.000127	0.000155	CcSEcCtD
Glycopyrrolate—Nervousness—Doxorubicin—hematologic cancer	0.000127	0.000155	CcSEcCtD
Glycopyrrolate—Constipation—Prednisone—hematologic cancer	0.000126	0.000154	CcSEcCtD
Glycopyrrolate—Palpitations—Epirubicin—hematologic cancer	0.000125	0.000153	CcSEcCtD
Glycopyrrolate—Confusional state—Methotrexate—hematologic cancer	0.000125	0.000152	CcSEcCtD
Glycopyrrolate—Dizziness—Triamcinolone—hematologic cancer	0.000124	0.000151	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Methotrexate—hematologic cancer	0.000124	0.000151	CcSEcCtD
Glycopyrrolate—Vision blurred—Doxorubicin—hematologic cancer	0.000124	0.000151	CcSEcCtD
Glycopyrrolate—Convulsion—Epirubicin—hematologic cancer	0.000123	0.00015	CcSEcCtD
Glycopyrrolate—Infection—Methotrexate—hematologic cancer	0.000123	0.00015	CcSEcCtD
Glycopyrrolate—Nausea—Etoposide—hematologic cancer	0.000123	0.000149	CcSEcCtD
Glycopyrrolate—Hypertension—Epirubicin—hematologic cancer	0.000122	0.000149	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Prednisone—hematologic cancer	0.000122	0.000149	CcSEcCtD
Glycopyrrolate—Asthenia—Betamethasone—hematologic cancer	0.000122	0.000149	CcSEcCtD
Glycopyrrolate—Asthenia—Dexamethasone—hematologic cancer	0.000122	0.000149	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Methotrexate—hematologic cancer	0.000121	0.000148	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Prednisone—hematologic cancer	0.000121	0.000147	CcSEcCtD
Glycopyrrolate—Nausea—Prednisolone—hematologic cancer	0.000121	0.000147	CcSEcCtD
Glycopyrrolate—Agitation—Doxorubicin—hematologic cancer	0.00012	0.000147	CcSEcCtD
Glycopyrrolate—Pruritus—Dexamethasone—hematologic cancer	0.00012	0.000146	CcSEcCtD
Glycopyrrolate—Pruritus—Betamethasone—hematologic cancer	0.00012	0.000146	CcSEcCtD
Glycopyrrolate—Skin disorder—Methotrexate—hematologic cancer	0.00012	0.000146	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.00012	0.000146	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Methotrexate—hematologic cancer	0.000119	0.000146	CcSEcCtD
Glycopyrrolate—Vomiting—Triamcinolone—hematologic cancer	0.000119	0.000145	CcSEcCtD
Glycopyrrolate—Rash—Triamcinolone—hematologic cancer	0.000118	0.000144	CcSEcCtD
Glycopyrrolate—Dry mouth—Epirubicin—hematologic cancer	0.000118	0.000144	CcSEcCtD
Glycopyrrolate—Dermatitis—Triamcinolone—hematologic cancer	0.000118	0.000144	CcSEcCtD
Glycopyrrolate—Urticaria—Prednisone—hematologic cancer	0.000117	0.000143	CcSEcCtD
Glycopyrrolate—Headache—Triamcinolone—hematologic cancer	0.000117	0.000143	CcSEcCtD
Glycopyrrolate—Body temperature increased—Prednisone—hematologic cancer	0.000117	0.000143	CcSEcCtD
Glycopyrrolate—Abdominal pain—Prednisone—hematologic cancer	0.000117	0.000143	CcSEcCtD
Glycopyrrolate—Confusional state—Epirubicin—hematologic cancer	0.000117	0.000142	CcSEcCtD
Glycopyrrolate—Palpitations—Doxorubicin—hematologic cancer	0.000116	0.000141	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Epirubicin—hematologic cancer	0.000116	0.000141	CcSEcCtD
Glycopyrrolate—Oedema—Epirubicin—hematologic cancer	0.000116	0.000141	CcSEcCtD
Glycopyrrolate—Hypotension—Methotrexate—hematologic cancer	0.000115	0.000141	CcSEcCtD
Glycopyrrolate—Infection—Epirubicin—hematologic cancer	0.000115	0.00014	CcSEcCtD
Glycopyrrolate—Convulsion—Doxorubicin—hematologic cancer	0.000114	0.000139	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Epirubicin—hematologic cancer	0.000113	0.000138	CcSEcCtD
Glycopyrrolate—Hypertension—Doxorubicin—hematologic cancer	0.000113	0.000138	CcSEcCtD
Glycopyrrolate—Tachycardia—Epirubicin—hematologic cancer	0.000113	0.000138	CcSEcCtD
Glycopyrrolate—Skin disorder—Epirubicin—hematologic cancer	0.000112	0.000137	CcSEcCtD
Glycopyrrolate—Dizziness—Betamethasone—hematologic cancer	0.000112	0.000137	CcSEcCtD
Glycopyrrolate—Dizziness—Dexamethasone—hematologic cancer	0.000112	0.000137	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Epirubicin—hematologic cancer	0.000112	0.000136	CcSEcCtD
Glycopyrrolate—Insomnia—Methotrexate—hematologic cancer	0.000112	0.000136	CcSEcCtD
Glycopyrrolate—Nausea—Triamcinolone—hematologic cancer	0.000111	0.000136	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	0.000111	0.000135	CcSEcCtD
Glycopyrrolate—Somnolence—Methotrexate—hematologic cancer	0.00011	0.000134	CcSEcCtD
Glycopyrrolate—Dry mouth—Doxorubicin—hematologic cancer	0.000109	0.000133	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Prednisone—hematologic cancer	0.000109	0.000133	CcSEcCtD
Glycopyrrolate—Dyspepsia—Methotrexate—hematologic cancer	0.000109	0.000133	CcSEcCtD
Glycopyrrolate—Hypotension—Epirubicin—hematologic cancer	0.000108	0.000132	CcSEcCtD
Glycopyrrolate—Vomiting—Betamethasone—hematologic cancer	0.000108	0.000132	CcSEcCtD
Glycopyrrolate—Vomiting—Dexamethasone—hematologic cancer	0.000108	0.000132	CcSEcCtD
Glycopyrrolate—Confusional state—Doxorubicin—hematologic cancer	0.000108	0.000132	CcSEcCtD
Glycopyrrolate—Rash—Dexamethasone—hematologic cancer	0.000107	0.000131	CcSEcCtD
Glycopyrrolate—Rash—Betamethasone—hematologic cancer	0.000107	0.000131	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000107	0.00013	CcSEcCtD
Glycopyrrolate—Oedema—Doxorubicin—hematologic cancer	0.000107	0.00013	CcSEcCtD
Glycopyrrolate—Dermatitis—Betamethasone—hematologic cancer	0.000107	0.00013	CcSEcCtD
Glycopyrrolate—Dermatitis—Dexamethasone—hematologic cancer	0.000107	0.00013	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000107	0.00013	CcSEcCtD
Glycopyrrolate—Fatigue—Methotrexate—hematologic cancer	0.000107	0.00013	CcSEcCtD
Glycopyrrolate—Headache—Dexamethasone—hematologic cancer	0.000106	0.00013	CcSEcCtD
Glycopyrrolate—Headache—Betamethasone—hematologic cancer	0.000106	0.00013	CcSEcCtD
Glycopyrrolate—Infection—Doxorubicin—hematologic cancer	0.000106	0.00013	CcSEcCtD
Glycopyrrolate—Asthenia—Prednisone—hematologic cancer	0.000106	0.000129	CcSEcCtD
Glycopyrrolate—Pain—Methotrexate—hematologic cancer	0.000106	0.000129	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Doxorubicin—hematologic cancer	0.000105	0.000128	CcSEcCtD
Glycopyrrolate—Pruritus—Prednisone—hematologic cancer	0.000105	0.000128	CcSEcCtD
Glycopyrrolate—Insomnia—Epirubicin—hematologic cancer	0.000105	0.000128	CcSEcCtD
Glycopyrrolate—Tachycardia—Doxorubicin—hematologic cancer	0.000104	0.000127	CcSEcCtD
Glycopyrrolate—Skin disorder—Doxorubicin—hematologic cancer	0.000104	0.000127	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000103	0.000126	CcSEcCtD
Glycopyrrolate—Somnolence—Epirubicin—hematologic cancer	0.000103	0.000125	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Methotrexate—hematologic cancer	0.000102	0.000124	CcSEcCtD
Glycopyrrolate—Dyspepsia—Epirubicin—hematologic cancer	0.000102	0.000124	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000101	0.000123	CcSEcCtD
Glycopyrrolate—Nausea—Betamethasone—hematologic cancer	0.000101	0.000123	CcSEcCtD
Glycopyrrolate—Nausea—Dexamethasone—hematologic cancer	0.000101	0.000123	CcSEcCtD
Glycopyrrolate—Hypotension—Doxorubicin—hematologic cancer	0.0001	0.000122	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Epirubicin—hematologic cancer	9.98e-05	0.000122	CcSEcCtD
Glycopyrrolate—Fatigue—Epirubicin—hematologic cancer	9.97e-05	0.000122	CcSEcCtD
Glycopyrrolate—Pain—Epirubicin—hematologic cancer	9.89e-05	0.000121	CcSEcCtD
Glycopyrrolate—Constipation—Epirubicin—hematologic cancer	9.89e-05	0.000121	CcSEcCtD
Glycopyrrolate—Urticaria—Methotrexate—hematologic cancer	9.82e-05	0.00012	CcSEcCtD
Glycopyrrolate—Dizziness—Prednisone—hematologic cancer	9.78e-05	0.000119	CcSEcCtD
Glycopyrrolate—Abdominal pain—Methotrexate—hematologic cancer	9.77e-05	0.000119	CcSEcCtD
Glycopyrrolate—Body temperature increased—Methotrexate—hematologic cancer	9.77e-05	0.000119	CcSEcCtD
Glycopyrrolate—Insomnia—Doxorubicin—hematologic cancer	9.68e-05	0.000118	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Epirubicin—hematologic cancer	9.53e-05	0.000116	CcSEcCtD
Glycopyrrolate—Somnolence—Doxorubicin—hematologic cancer	9.51e-05	0.000116	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Epirubicin—hematologic cancer	9.46e-05	0.000115	CcSEcCtD
Glycopyrrolate—Dyspepsia—Doxorubicin—hematologic cancer	9.42e-05	0.000115	CcSEcCtD
Glycopyrrolate—Vomiting—Prednisone—hematologic cancer	9.4e-05	0.000115	CcSEcCtD
Glycopyrrolate—Rash—Prednisone—hematologic cancer	9.32e-05	0.000114	CcSEcCtD
Glycopyrrolate—Dermatitis—Prednisone—hematologic cancer	9.32e-05	0.000114	CcSEcCtD
Glycopyrrolate—Headache—Prednisone—hematologic cancer	9.26e-05	0.000113	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.24e-05	0.000113	CcSEcCtD
Glycopyrrolate—Fatigue—Doxorubicin—hematologic cancer	9.23e-05	0.000112	CcSEcCtD
Glycopyrrolate—Urticaria—Epirubicin—hematologic cancer	9.19e-05	0.000112	CcSEcCtD
Glycopyrrolate—Pain—Doxorubicin—hematologic cancer	9.15e-05	0.000112	CcSEcCtD
Glycopyrrolate—Constipation—Doxorubicin—hematologic cancer	9.15e-05	0.000112	CcSEcCtD
Glycopyrrolate—Body temperature increased—Epirubicin—hematologic cancer	9.14e-05	0.000111	CcSEcCtD
Glycopyrrolate—Abdominal pain—Epirubicin—hematologic cancer	9.14e-05	0.000111	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Methotrexate—hematologic cancer	9.11e-05	0.000111	CcSEcCtD
Glycopyrrolate—Asthenia—Methotrexate—hematologic cancer	8.87e-05	0.000108	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Doxorubicin—hematologic cancer	8.82e-05	0.000108	CcSEcCtD
Glycopyrrolate—Nausea—Prednisone—hematologic cancer	8.78e-05	0.000107	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Doxorubicin—hematologic cancer	8.75e-05	0.000107	CcSEcCtD
Glycopyrrolate—Pruritus—Methotrexate—hematologic cancer	8.74e-05	0.000107	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Epirubicin—hematologic cancer	8.52e-05	0.000104	CcSEcCtD
Glycopyrrolate—Urticaria—Doxorubicin—hematologic cancer	8.5e-05	0.000104	CcSEcCtD
Glycopyrrolate—Abdominal pain—Doxorubicin—hematologic cancer	8.46e-05	0.000103	CcSEcCtD
Glycopyrrolate—Body temperature increased—Doxorubicin—hematologic cancer	8.46e-05	0.000103	CcSEcCtD
Glycopyrrolate—Asthenia—Epirubicin—hematologic cancer	8.3e-05	0.000101	CcSEcCtD
Glycopyrrolate—Pruritus—Epirubicin—hematologic cancer	8.18e-05	9.98e-05	CcSEcCtD
Glycopyrrolate—Dizziness—Methotrexate—hematologic cancer	8.17e-05	9.96e-05	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Doxorubicin—hematologic cancer	7.88e-05	9.61e-05	CcSEcCtD
Glycopyrrolate—Vomiting—Methotrexate—hematologic cancer	7.86e-05	9.58e-05	CcSEcCtD
Glycopyrrolate—Rash—Methotrexate—hematologic cancer	7.79e-05	9.5e-05	CcSEcCtD
Glycopyrrolate—Dermatitis—Methotrexate—hematologic cancer	7.78e-05	9.49e-05	CcSEcCtD
Glycopyrrolate—Headache—Methotrexate—hematologic cancer	7.74e-05	9.44e-05	CcSEcCtD
Glycopyrrolate—Asthenia—Doxorubicin—hematologic cancer	7.68e-05	9.36e-05	CcSEcCtD
Glycopyrrolate—Dizziness—Epirubicin—hematologic cancer	7.65e-05	9.33e-05	CcSEcCtD
Glycopyrrolate—Pruritus—Doxorubicin—hematologic cancer	7.57e-05	9.23e-05	CcSEcCtD
Glycopyrrolate—Vomiting—Epirubicin—hematologic cancer	7.35e-05	8.97e-05	CcSEcCtD
Glycopyrrolate—Nausea—Methotrexate—hematologic cancer	7.34e-05	8.95e-05	CcSEcCtD
Glycopyrrolate—Rash—Epirubicin—hematologic cancer	7.29e-05	8.89e-05	CcSEcCtD
Glycopyrrolate—Dermatitis—Epirubicin—hematologic cancer	7.29e-05	8.88e-05	CcSEcCtD
Glycopyrrolate—Headache—Epirubicin—hematologic cancer	7.25e-05	8.83e-05	CcSEcCtD
Glycopyrrolate—Dizziness—Doxorubicin—hematologic cancer	7.08e-05	8.63e-05	CcSEcCtD
Glycopyrrolate—Nausea—Epirubicin—hematologic cancer	6.87e-05	8.38e-05	CcSEcCtD
Glycopyrrolate—Vomiting—Doxorubicin—hematologic cancer	6.8e-05	8.3e-05	CcSEcCtD
Glycopyrrolate—Rash—Doxorubicin—hematologic cancer	6.75e-05	8.23e-05	CcSEcCtD
Glycopyrrolate—Dermatitis—Doxorubicin—hematologic cancer	6.74e-05	8.22e-05	CcSEcCtD
Glycopyrrolate—Headache—Doxorubicin—hematologic cancer	6.7e-05	8.17e-05	CcSEcCtD
Glycopyrrolate—Nausea—Doxorubicin—hematologic cancer	6.36e-05	7.75e-05	CcSEcCtD
Glycopyrrolate—CHRM3—Metabolism—PIK3CG—hematologic cancer	2.03e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL2—hematologic cancer	2.03e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL2—hematologic cancer	2.03e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TERT—hematologic cancer	2.02e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	2.02e-05	0.000112	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TERT—hematologic cancer	2.02e-05	0.000112	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3R1—hematologic cancer	2.01e-05	0.000112	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL2—hematologic cancer	2.01e-05	0.000112	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—PIK3CA—hematologic cancer	2e-05	0.000111	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TERT—hematologic cancer	2e-05	0.000111	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MDM2—hematologic cancer	1.99e-05	0.000111	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PDGFB—hematologic cancer	1.98e-05	0.00011	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PDGFB—hematologic cancer	1.97e-05	0.00011	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—JAK2—hematologic cancer	1.95e-05	0.000109	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	1.95e-05	0.000108	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MTOR—hematologic cancer	1.94e-05	0.000108	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CB—hematologic cancer	1.94e-05	0.000108	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TSC2—hematologic cancer	1.93e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TSC2—hematologic cancer	1.93e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—PIK3CA—hematologic cancer	1.92e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MDM2—hematologic cancer	1.91e-05	0.000106	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TSC2—hematologic cancer	1.91e-05	0.000106	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CREBBP—hematologic cancer	1.89e-05	0.000105	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FGFR3—hematologic cancer	1.86e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MTOR—hematologic cancer	1.86e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CB—hematologic cancer	1.86e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FGFR3—hematologic cancer	1.85e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—HRAS—hematologic cancer	1.85e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAPK14—hematologic cancer	1.84e-05	0.000102	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	1.83e-05	0.000102	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAPK14—hematologic cancer	1.83e-05	0.000102	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CDKN1B—hematologic cancer	1.82e-05	0.000101	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	1.82e-05	0.000101	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ESR1—hematologic cancer	1.8e-05	0.0001	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—AKT1—hematologic cancer	1.8e-05	0.0001	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ESR1—hematologic cancer	1.8e-05	0.0001	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CD—hematologic cancer	1.79e-05	9.94e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CASP3—hematologic cancer	1.78e-05	9.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FN1—hematologic cancer	1.78e-05	9.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ESR1—hematologic cancer	1.78e-05	9.9e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL2—hematologic cancer	1.78e-05	9.9e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FN1—hematologic cancer	1.78e-05	9.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—HRAS—hematologic cancer	1.77e-05	9.85e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6—hematologic cancer	1.77e-05	9.85e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALB—hematologic cancer	1.77e-05	9.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NFKBIA—hematologic cancer	1.76e-05	9.79e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—BAD—hematologic cancer	1.76e-05	9.79e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FN1—hematologic cancer	1.76e-05	9.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NFKBIA—hematologic cancer	1.76e-05	9.76e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—BAD—hematologic cancer	1.76e-05	9.76e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOTCH1—hematologic cancer	1.74e-05	9.7e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CDKN1B—hematologic cancer	1.74e-05	9.69e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOTCH1—hematologic cancer	1.74e-05	9.67e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—BAD—hematologic cancer	1.74e-05	9.67e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	1.74e-05	9.67e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCND1—hematologic cancer	1.74e-05	9.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—JUN—hematologic cancer	1.73e-05	9.63e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—AKT1—hematologic cancer	1.72e-05	9.58e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	1.72e-05	9.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CD80—hematologic cancer	1.71e-05	9.5e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CASP3—hematologic cancer	1.71e-05	9.49e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	1.71e-05	9.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KIT—hematologic cancer	1.71e-05	9.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	1.71e-05	9.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL2—hematologic cancer	1.71e-05	9.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CD80—hematologic cancer	1.7e-05	9.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CG—hematologic cancer	1.7e-05	9.45e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KIT—hematologic cancer	1.7e-05	9.45e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—NRAS—hematologic cancer	1.7e-05	9.45e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6—hematologic cancer	1.7e-05	9.43e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3R1—hematologic cancer	1.69e-05	9.39e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CD80—hematologic cancer	1.69e-05	9.38e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	1.68e-05	9.36e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KIT—hematologic cancer	1.68e-05	9.36e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	1.68e-05	9.36e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CDKN1A—hematologic cancer	1.68e-05	9.33e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	1.68e-05	9.32e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PTEN—hematologic cancer	1.68e-05	9.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTPN11—hematologic cancer	1.67e-05	9.29e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCND1—hematologic cancer	1.66e-05	9.24e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—JUN—hematologic cancer	1.66e-05	9.22e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	1.65e-05	9.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MAPK8—hematologic cancer	1.64e-05	9.11e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—AKT1—hematologic cancer	1.63e-05	9.09e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	1.63e-05	9.08e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—MAPK3—hematologic cancer	1.63e-05	9.05e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CREB1—hematologic cancer	1.62e-05	9.03e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CREB1—hematologic cancer	1.62e-05	9e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	1.61e-05	8.97e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CDKN1A—hematologic cancer	1.61e-05	8.94e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PTEN—hematologic cancer	1.6e-05	8.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—BRAF—hematologic cancer	1.6e-05	8.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CREB1—hematologic cancer	1.6e-05	8.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—BRAF—hematologic cancer	1.6e-05	8.89e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EP300—hematologic cancer	1.6e-05	8.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL2—hematologic cancer	1.59e-05	8.83e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6R—hematologic cancer	1.58e-05	8.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL2—hematologic cancer	1.58e-05	8.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—BRAF—hematologic cancer	1.58e-05	8.8e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	1.58e-05	8.79e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6R—hematologic cancer	1.58e-05	8.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CREBBP—hematologic cancer	1.58e-05	8.77e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MAPK8—hematologic cancer	1.57e-05	8.73e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL2—hematologic cancer	1.57e-05	8.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—AKT1—hematologic cancer	1.57e-05	8.7e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6R—hematologic cancer	1.56e-05	8.69e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	1.56e-05	8.68e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CB—hematologic cancer	1.56e-05	8.66e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SRC—hematologic cancer	1.55e-05	8.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EP300—hematologic cancer	1.53e-05	8.51e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—VEGFA—hematologic cancer	1.51e-05	8.41e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	1.51e-05	8.39e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	1.5e-05	8.37e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	1.5e-05	8.34e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—STAT3—hematologic cancer	1.5e-05	8.33e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	1.5e-05	8.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NRAS—hematologic cancer	1.49e-05	8.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	1.49e-05	8.29e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SRC—hematologic cancer	1.49e-05	8.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.49e-05	8.26e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	1.48e-05	8.23e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	1.48e-05	8.23e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	1.47e-05	8.16e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.47e-05	8.15e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	1.46e-05	8.14e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	1.45e-05	8.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—VEGFA—hematologic cancer	1.45e-05	8.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FGF2—hematologic cancer	1.44e-05	7.98e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—STAT3—hematologic cancer	1.43e-05	7.98e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FGF2—hematologic cancer	1.43e-05	7.96e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MAPK3—hematologic cancer	1.43e-05	7.96e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NRAS—hematologic cancer	1.43e-05	7.96e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FGF2—hematologic cancer	1.42e-05	7.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	1.42e-05	7.87e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	1.41e-05	7.85e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	1.4e-05	7.77e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MYC—hematologic cancer	1.39e-05	7.74e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TGFB1—hematologic cancer	1.39e-05	7.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—JAK2—hematologic cancer	1.38e-05	7.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—JAK2—hematologic cancer	1.37e-05	7.63e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MAPK3—hematologic cancer	1.37e-05	7.62e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—JAK2—hematologic cancer	1.36e-05	7.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	1.35e-05	7.5e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTEN—hematologic cancer	1.35e-05	7.49e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	1.34e-05	7.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MDM2—hematologic cancer	1.34e-05	7.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MDM2—hematologic cancer	1.34e-05	7.45e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MYC—hematologic cancer	1.33e-05	7.41e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	1.33e-05	7.4e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TGFB1—hematologic cancer	1.33e-05	7.39e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MDM2—hematologic cancer	1.33e-05	7.37e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	1.31e-05	7.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MTOR—hematologic cancer	1.31e-05	7.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MTOR—hematologic cancer	1.3e-05	7.24e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	1.3e-05	7.24e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MTOR—hematologic cancer	1.29e-05	7.17e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	1.29e-05	7.17e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—KRAS—hematologic cancer	1.29e-05	7.15e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—EP300—hematologic cancer	1.28e-05	7.14e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	1.25e-05	6.94e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	1.24e-05	6.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	1.23e-05	6.85e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—KRAS—hematologic cancer	1.23e-05	6.85e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	1.23e-05	6.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	1.22e-05	6.8e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	1.21e-05	6.75e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	1.21e-05	6.73e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	1.21e-05	6.73e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CASP3—hematologic cancer	1.2e-05	6.68e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL2—hematologic cancer	1.2e-05	6.67e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CASP3—hematologic cancer	1.2e-05	6.66e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	1.2e-05	6.66e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL2—hematologic cancer	1.2e-05	6.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6—hematologic cancer	1.19e-05	6.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6—hematologic cancer	1.19e-05	6.62e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CASP3—hematologic cancer	1.19e-05	6.6e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL2—hematologic cancer	1.19e-05	6.59e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CA—hematologic cancer	1.18e-05	6.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6—hematologic cancer	1.18e-05	6.56e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCND1—hematologic cancer	1.17e-05	6.51e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—JUN—hematologic cancer	1.17e-05	6.49e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCND1—hematologic cancer	1.17e-05	6.49e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—JUN—hematologic cancer	1.16e-05	6.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCND1—hematologic cancer	1.16e-05	6.42e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—JUN—hematologic cancer	1.15e-05	6.41e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TP53—hematologic cancer	1.14e-05	6.36e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	1.13e-05	6.29e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CA—hematologic cancer	1.13e-05	6.29e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTEN—hematologic cancer	1.13e-05	6.28e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	1.13e-05	6.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTEN—hematologic cancer	1.13e-05	6.26e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	1.12e-05	6.21e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTEN—hematologic cancer	1.12e-05	6.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	1.11e-05	6.14e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	1.1e-05	6.13e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	1.1e-05	6.12e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	1.1e-05	6.11e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TP53—hematologic cancer	1.09e-05	6.09e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HRAS—hematologic cancer	1.09e-05	6.08e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	1.09e-05	6.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	1.09e-05	6.05e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EP300—hematologic cancer	1.08e-05	5.99e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EP300—hematologic cancer	1.07e-05	5.97e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EP300—hematologic cancer	1.06e-05	5.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SRC—hematologic cancer	1.05e-05	5.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HRAS—hematologic cancer	1.05e-05	5.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6—hematologic cancer	1.05e-05	5.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SRC—hematologic cancer	1.04e-05	5.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SRC—hematologic cancer	1.03e-05	5.75e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	1.02e-05	5.67e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	1.02e-05	5.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—STAT3—hematologic cancer	1.01e-05	5.62e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NRAS—hematologic cancer	1.01e-05	5.6e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	1.01e-05	5.6e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—STAT3—hematologic cancer	1.01e-05	5.6e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NRAS—hematologic cancer	1e-05	5.59e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6—hematologic cancer	1e-05	5.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—STAT3—hematologic cancer	9.97e-06	5.54e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NRAS—hematologic cancer	9.95e-06	5.53e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AKT1—hematologic cancer	9.66e-06	5.37e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	9.65e-06	5.37e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	9.62e-06	5.35e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	9.53e-06	5.3e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CA—hematologic cancer	9.5e-06	5.28e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MYC—hematologic cancer	9.39e-06	5.22e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	9.36e-06	5.21e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MYC—hematologic cancer	9.36e-06	5.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	9.34e-06	5.19e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MYC—hematologic cancer	9.27e-06	5.15e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AKT1—hematologic cancer	9.25e-06	5.14e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	9.24e-06	5.14e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KRAS—hematologic cancer	8.67e-06	4.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KRAS—hematologic cancer	8.65e-06	4.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KRAS—hematologic cancer	8.56e-06	4.76e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	7.97e-06	4.43e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	7.94e-06	4.42e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	7.87e-06	4.37e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AKT1—hematologic cancer	7.76e-06	4.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TP53—hematologic cancer	7.71e-06	4.29e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TP53—hematologic cancer	7.68e-06	4.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TP53—hematologic cancer	7.61e-06	4.23e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HRAS—hematologic cancer	7.37e-06	4.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HRAS—hematologic cancer	7.35e-06	4.09e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HRAS—hematologic cancer	7.28e-06	4.05e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6—hematologic cancer	7.06e-06	3.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6—hematologic cancer	7.03e-06	3.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6—hematologic cancer	6.97e-06	3.87e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKT1—hematologic cancer	6.51e-06	3.62e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKT1—hematologic cancer	6.49e-06	3.61e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKT1—hematologic cancer	6.43e-06	3.57e-05	CbGpPWpGaD
